reference/28725923

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28725923

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	37
issn	0960-314X
issueIdentifier	1
pageRange	31-37
publicationName	Pharmacogenetics
startingPage	31
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e921a1abad1677540ca6499203525ed6 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a0feeaf1c99bdadae25144b538a4d2bd
bibliographicCitation	Fleming RA, Drees J, Loggie BW, Russell GB, Geisinger KR, Morris RT, Sachs D, McQuellon RP. Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C. Pharmacogenetics. 2002 Jan;12(1):31–7. doi: 10.1097/00008571-200201000-00005. PMID: 11773862.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_71fc28a58c67b9a47ae9dbd4dde0abb7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b6458a0ecd9de2f46b20342f99fd93f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f634a10c9bce457af0164a22e03b8f0c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d540b1a65da19f8861019e943fa5d74a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf3cfa4e1825f0bf1e004d8eb00f5ead http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_104adc6f9d8ae12ea39a1535041d520e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c07ba375f6e8a7a887bae5260c4312ad http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82232b30432666f18dea033bace8c5b3
date	200201
identifier	https://doi.org/10.1097/00008571-200201000-00005 https://pubmed.ncbi.nlm.nih.gov/11773862
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2424 https://portal.issn.org/resource/ISSN/0960-314X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C
discusses	http://id.nlm.nih.gov/mesh/M0001348 http://id.nlm.nih.gov/mesh/M0013948 http://id.nlm.nih.gov/mesh/M0027090 http://id.nlm.nih.gov/mesh/M0025387
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D010534Q000235 http://id.nlm.nih.gov/mesh/D016685Q000627 http://id.nlm.nih.gov/mesh/D010534Q000188 http://id.nlm.nih.gov/mesh/D016660Q000235 http://id.nlm.nih.gov/mesh/D011110 http://id.nlm.nih.gov/mesh/D000903Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D005838 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D010534Q000201 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D017931Q000737 http://id.nlm.nih.gov/mesh/D010478 http://id.nlm.nih.gov/mesh/D016133 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D012150 http://id.nlm.nih.gov/mesh/D006979 http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7732 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4650 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5746 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8857 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.6.5.5

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127481953 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1728

Total number of triples: 62.